INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,809,110 | -12.8% | 20,074,832 | +0.0% | 0.00% | – |
| Q2 2023 | $8,960,310 | -40.2% | 20,067,883 | +9.9% | 0.00% | – |
| Q1 2023 | $14,977,062 | -43.7% | 18,264,711 | +7.2% | 0.00% | -100.0% |
| Q4 2022 | $26,586,300 | +0.2% | 17,042,500 | +10.8% | 0.00% | 0.0% |
| Q3 2022 | $26,534,000 | +14.7% | 15,382,309 | +15.0% | 0.00% | 0.0% |
| Q2 2022 | $23,133,000 | -42.7% | 13,371,591 | +18.9% | 0.00% | 0.0% |
| Q1 2022 | $40,381,000 | -26.7% | 11,247,922 | +1.9% | 0.00% | 0.0% |
| Q4 2021 | $55,086,000 | -29.8% | 11,039,313 | +0.8% | 0.00% | -50.0% |
| Q3 2021 | $78,449,000 | -22.7% | 10,956,586 | +0.1% | 0.00% | -33.3% |
| Q2 2021 | $101,491,000 | -4.8% | 10,948,320 | -4.7% | 0.00% | 0.0% |
| Q1 2021 | $106,621,000 | +31.2% | 11,489,304 | +25.1% | 0.00% | +50.0% |
| Q4 2020 | $81,293,000 | -25.1% | 9,185,639 | -1.8% | 0.00% | -50.0% |
| Q3 2020 | $108,463,000 | -58.0% | 9,350,245 | -2.5% | 0.00% | -55.6% |
| Q2 2020 | $258,323,000 | +520.7% | 9,585,288 | +71.3% | 0.01% | +350.0% |
| Q1 2020 | $41,620,000 | +149.6% | 5,594,111 | +10.7% | 0.00% | +100.0% |
| Q4 2019 | $16,673,000 | +59.1% | 5,052,394 | -1.2% | 0.00% | – |
| Q3 2019 | $10,480,000 | -26.7% | 5,112,037 | +5.2% | 0.00% | -100.0% |
| Q2 2019 | $14,289,000 | -20.6% | 4,860,200 | +0.7% | 0.00% | 0.0% |
| Q1 2019 | $17,998,000 | -1.1% | 4,825,182 | +6.1% | 0.00% | 0.0% |
| Q4 2018 | $18,189,000 | -22.9% | 4,547,107 | +7.2% | 0.00% | 0.0% |
| Q3 2018 | $23,593,000 | +48.3% | 4,243,379 | +4.5% | 0.00% | 0.0% |
| Q2 2018 | $15,911,000 | -13.6% | 4,058,922 | +3.8% | 0.00% | 0.0% |
| Q1 2018 | $18,411,000 | +14.7% | 3,908,824 | +0.6% | 0.00% | 0.0% |
| Q4 2017 | $16,045,000 | -33.1% | 3,884,858 | +2.8% | 0.00% | 0.0% |
| Q3 2017 | $23,966,000 | -5.3% | 3,780,050 | +17.1% | 0.00% | 0.0% |
| Q2 2017 | $25,301,000 | +23.4% | 3,227,219 | +4.2% | 0.00% | 0.0% |
| Q1 2017 | $20,510,000 | +2.9% | 3,098,055 | +7.9% | 0.00% | 0.0% |
| Q4 2016 | $19,926,000 | -24.0% | 2,871,194 | +2.1% | 0.00% | -50.0% |
| Q3 2016 | $26,206,000 | +1.5% | 2,811,712 | +0.6% | 0.00% | 0.0% |
| Q2 2016 | $25,818,000 | +10.7% | 2,794,169 | +4.4% | 0.00% | 0.0% |
| Q1 2016 | $23,318,000 | +39.9% | 2,677,113 | +7.9% | 0.00% | +100.0% |
| Q4 2015 | $16,665,000 | -41.1% | 2,479,977 | -49.3% | 0.00% | 0.0% |
| Q3 2015 | $28,276,000 | +51.4% | 4,891,974 | +113.8% | 0.00% | 0.0% |
| Q2 2015 | $18,674,000 | +13.4% | 2,288,499 | +13.4% | 0.00% | 0.0% |
| Q1 2015 | $16,473,000 | -7.1% | 2,018,724 | +4.5% | 0.00% | 0.0% |
| Q4 2014 | $17,730,000 | +3.4% | 1,931,268 | +10.9% | 0.00% | 0.0% |
| Q3 2014 | $17,155,000 | -5.5% | 1,741,662 | +3.8% | 0.00% | 0.0% |
| Q2 2014 | $18,144,000 | – | 1,678,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |